The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Abramova A.A.
Research Center of Neurology, Moscow, Russia
Zakroyshchikova I.V.
Research Center of Neurology, Moscow, Russia
Krotenkova I.A.
Research Center of Neurology, Moscow, Russia
Kochergin I.A.
Research Center of Neurology, Moscow, Russia
Zakharova M.N.
Research Center of Neurology, Moscow, Russia
Leptomeningeal B-cell follicles in multiple sclerosis: a role in the pathogenesis and prognostic value
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(10‑2): 21‑27
Views: 4416
Downloaded: 102
To cite this article:
Abramova AA, Zakroyshchikova IV, Krotenkova IA, Kochergin IA, Zakharova MN. Leptomeningeal B-cell follicles in multiple sclerosis: a role in the pathogenesis and prognostic value. S.S. Korsakov Journal of Neurology and Psychiatry.
2019;119(10‑2):21‑27. (In Russ.)
https://doi.org/10.17116/jnevro201911910221
B-lymphocytes play an important role in the development and maintenance of the inflammatory process in multiple sclerosis. Recently special attention has been paid to cell formations that are found in the meninges in patients with multiple sclerosis — the so-called leptomeningeal follicle-like structures that contain not only B-lymphocytes, but also other immunocompetent cells, creating a special environment for clonal expansion, selection and further proliferation of B-lymphocytes. Magnetic resonance imaging (MRI) of the brain with gadolinium-based contrast agents reveals local subarachnoid space contrasting that corresponds to the accumulation of the contrast agent by large lymphoid follicles. This phenomenon is called leptomeningeal contrast enhancement and according to some literature data, its severity correlates with the rate of progression of the disease and functional disability. The review presents the available literature on leptomeningeal follicle-like B-cell structures, as well as prospects of using leptomeningeal contrast enhancement on MRI as a potential biomarker for predicting disease severity in patients with multiple sclerosis.
Keywords:
Authors:
Abramova A.A.
Research Center of Neurology, Moscow, Russia
Zakroyshchikova I.V.
Research Center of Neurology, Moscow, Russia
Krotenkova I.A.
Research Center of Neurology, Moscow, Russia
Kochergin I.A.
Research Center of Neurology, Moscow, Russia
Zakharova M.N.
Research Center of Neurology, Moscow, Russia
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.